CJC-1295 / Ipamorelin Chicago — Chicagoland Peptides
CJC-1295 (a GHRH-pathway analog) and Ipamorelin (a selective secretagogue) are co-listed because pituitary pulse experiments often run them together. Laboratory notes emphasise timed hormone-axis sampling rather than replacement paradigms for Chicago and Chicagoland research buyers.
Lab report
Chicagoland Peptides products are Research Use Only ("RUO") and are intended solely for basic research, pharmaceutical research, laboratory experimentation, or the development of new tests — not for diagnosing, treating, curing, or preventing any disease or condition in any patient. These statements have not been evaluated by the U.S. Food and Drug Administration.